Abstral

Drug Sentynl Therapeutics, Inc.
Total Payments
$12,840
Transactions
66
Doctors
13
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $12,737 59 8
2017 $102.88 7 5

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $11,494 9 89.5%
Travel and Lodging $1,185 40 9.2%
Food and Beverage $160.85 17 1.3%

Top Doctors Receiving Payments for Abstral

Doctor Specialty Location Total Records
, M.D Anesthesiology Naples, FL $4,264 17
, MD Internal Medicine Princeton, NJ $1,424 6
, MD Anesthesiology New Orleans, LA $1,386 7
, M.D Pediatric Nephrology New York, NY $1,386 7
, MD Internal Medicine Philadelphia, PA $1,358 5
, MD Internal Medicine Baltimore, MD $1,039 4
, M.D., PH.D Clinical Pharmacology Kansas City, MO $1,013 6
, M.D Pulmonary Disease Park Ridge, NJ $867.58 7
, M.D Hematology & Oncology Flushing, NY $42.64 3
, M.D Interventional Pain Medicine Babylon, NY $17.15 1
, M.D Anesthesiology Babylon, NY $17.14 1
, M.D Pain Medicine Patchogue, NY $16.04 1
, MD Pain Medicine Hendersonville, TN $9.91 1

About Abstral

Abstral is a drug associated with $12,840 in payments to 13 healthcare providers, recorded across 66 transactions in the CMS Open Payments database. The primary manufacturer is Sentynl Therapeutics, Inc..

Payment data is available from 2017 to 2018. In 2018, $12,737 was paid across 59 transactions to 8 doctors.

The most common payment nature for Abstral is "Consulting Fee" ($11,494, 89.5% of total).